Cite
HARVARD Citation
Griffith, D. et al. (n.d.). 218. A Phase 1 Study of the Single-Dose Safety, Tolerability, and Pharmacokinetics of the Beta-lactamase inhibitor Xeruborbactam Administered as the Isobutyryloxymethyl Oral Prodrug to Healthy Adult Subjects. Open forum infectious diseases. p. . [Online].